Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Operation for N2 small cell lung carcinoma.

G M Salzer1, L C Müller, H Huber

  • 1Department of Surgery II, University of Innsbruck, Austria.

The Annals of Thoracic Surgery
|May 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Not Available].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author

[Integration of the radiotherapy irradiation planning in the digital workflow].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2013
Same author

[Development of radiation oncology into an independent clinical specialty. A more personal reflection].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2012
Same author

Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants.

Journal of breath research·2012
Same author

Decline of exhaled isoprene in lung cancer patients correlates with immune activation.

Journal of breath research·2012
Same author

In-medium isovector piN amplitude from low-energy pion scattering.

Physical review letters·2004

Radical surgery combined with comprehensive therapy significantly improves survival for patients with N2 small cell lung cancer (SCLC). This multimodal approach offers encouraging outcomes for this challenging SCLC stage.

Area of Science:

  • Thoracic Surgery
  • Medical Oncology
  • Radiation Oncology

Background:

  • Small cell lung carcinoma (SCLC) with N2 lymph node metastases presents a significant therapeutic challenge.
  • Historically, radical resection for N2 SCLC has been approached with caution.

Purpose of the Study:

  • To evaluate the outcomes of multimodal therapy, including radical resection, for limited small cell lung carcinoma with N2 lymph node involvement.
  • To assess the impact of comprehensive treatment protocols on survival rates in this patient cohort.

Main Methods:

  • Retrospective analysis of 48 patients with limited SCLC, focusing on a subgroup of 25 with N2 metastases.
  • Comparison of treatment outcomes between historical approaches (resection alone, resection with adjuvant therapy) and a comprehensive protocol (resection, chemotherapy, radiotherapy, prophylactic cranial irradiation) implemented since 1977.

Related Experiment Videos

  • Detailed reporting of survival data for patients receiving comprehensive therapy.

    • Main Results:

    • The projected 5-year survival rate for the entire N2 group was 25%.
    • Patients treated with the comprehensive protocol demonstrated a projected 5-year survival rate of 47%.
    • An observed 2-year survival rate of 38% was achieved in the comprehensively treated group, with seven patients alive at extended follow-up intervals.

    Conclusions:

    • Comprehensive multimodal therapy, integrating radical resection with chemotherapy and radiotherapy, significantly improves survival for N2 SCLC patients.
    • Radical lung resection should be considered for N2 SCLC when incorporated into a well-defined multimodal therapeutic strategy.
    • This study represents the largest reported series of resected N2 SCLC treated at a single institution, providing encouraging evidence for aggressive, combined-modality treatment.